Crosslinkable biological material and medical uses
First Claim
1. A method for promoting angiogenesis in a subject in need thereof, comprising administering to said subject a substrate loaded with therapeutically effective amount of a non-protein angiogenesis factor.
1 Assignment
0 Petitions
Accused Products
Abstract
A method for promoting angiogenesis in a patient comprising providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least one angiogenic agent. In one embodiment, the at least one angiogenic agent is a non-protein factor selected from a group consisting of ginsenoside Rg1, ginsenoside Re, combination thereof and the like. In another embodiment, the crosslinkable biological solution of the present invention is broadly defined in a form or phase of solution, paste, gel, suspension, colloid or plasma that may be solidifiable thereafter.
-
Citations
20 Claims
- 1. A method for promoting angiogenesis in a subject in need thereof, comprising administering to said subject a substrate loaded with therapeutically effective amount of a non-protein angiogenesis factor.
-
9. A method for promoting angiogenesis for treating tissue, comprising:
- providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least one angiogenesis factor.
- View Dependent Claims (10, 11, 12, 13)
- 14. A crosslinkable biological solution kit comprising a first readily mixable crosslinkable biological solution component and a second crosslinker component, wherein the first component and the second component are mixed at point of need.
Specification